Barcelona, March 2017 - Sagetis Biotech is pleased to announce that Sagetis’ Chief Executive Officer, Eduard Diviu, will be attending Biovision World Life Sciences Forum in Lyon (France) from the 4th - 6th April 2017. If you wish to meet with us, please get in touch and we will arrange a meeting.
Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors.
Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2016 edition of the BIOVISION life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.
About Sagetis Biotech
Sagetis Biotech is devoted to developing an innovative gene delivery technology to overcome a fundamental engineering challenge in gene therapy: the development of safe and effective delivery vectors. Privately funded and based in Barcelona, Sagetis Biotech was founded in 2010 as a spin-off from GEMAT (Materials Engineering Group) at IQS.